Group 1 - The Investment Doctor plans to increase exposure to fixed income securities in 2026, emphasizing the importance of interest and dividend income as the backbone of the portfolio [1] - The focus is on European small-cap stocks with a 5-7 year investment horizon, aiming for a mix of dividend and growth stocks [1] - The investment group European Small Cap Ideas provides exclusive access to actionable research on European investment opportunities, highlighting high-quality small-cap ideas for capital gains and continuous cash flow [1] Group 2 - The investment group features two model portfolios: the European Small Cap Ideas portfolio and the European REIT Portfolio, along with weekly updates and educational content [1] - An active chat room is available for discussions on the latest developments of the portfolio holdings [1]

Group 1 - The Investment Doctor plans to increase exposure to fixed income securities in 2026, emphasizing the importance of interest and dividend income as the backbone of the portfolio [1] - The focus is on European small-cap stocks with a 5-7 year investment horizon, aiming for a mix of dividend and growth stocks [1] - The investment group European Small Cap Ideas provides exclusive access to actionable research on European investment opportunities, highlighting high-quality small-cap ideas for capital gains and continuous cash flow [1] Group 2 - The investment group features two model portfolios: the European Small Cap Ideas portfolio and the European REIT Portfolio, along with weekly updates and educational content [1] - An active chat room is available for discussions on the latest developments of the portfolio holdings [1]

Core Insights - Preferred shares have been utilized for over 200 years, with the Pennsylvania Railroad Company issuing perpetual preferreds at a 6% coupon in 1878 to raise capital without diluting shareholders [1] Group 1: Investment Strategy - The service led by Rida Morwa focuses on sustainable income through high-yield investments, targeting a safe +9% yield [1] - Features of the service include a model portfolio with buy/sell alerts, preferred and baby bond portfolios for conservative investors, and regular market updates [1] Group 2: Community and Education - The service emphasizes community and education, promoting the belief that investors should not invest alone [1]

CHARLOTTE, N.C., Dec. 16, 2025 /PRNewswire/ -- Bank of America Corporation today announced the Board of Directors has authorized regular cash dividends on the outstanding shares or depositary shares of the following series of preferred stock:  Series of Preferred Stock Dividend per Shareor Depositary Share1 Record Date Payment Date 7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L $18.1250000 January 1 January 30 5.875% Non-Cumulative Preferred Stock, Series HH $0.3671875 Janua ...

分组1 - The article focuses on Global Medical REIT Inc. and its potential as a fixed-income security investment opportunity [1] - The investment group Trade With Beta, led by Denislav Iliev, identifies mispriced investments in fixed-income and closed-end funds [1] - The service includes features such as frequent picks for mispriced preferred stocks and baby bonds, weekly reviews of over 1200 equities, IPO previews, and hedging strategies [1]

Core Points - The Allstate Corporation's board of directors approved a quarterly common stock dividend of $1.00 [1] - The dividend is payable in cash on January 2, 2026, to stockholders of record at the close of business on December 1, 2025 [1] - Allstate also declared the payment of quarterly preferred dividends [1]

Core Points - Wells Fargo & Company has declared dividends on six series of preferred stock, reflecting its ongoing commitment to returning value to shareholders [1][2][3][4][5][6][7] Dividend Details - A quarterly cash dividend of $18.75 per share was declared on its 7.50% noncumulative perpetual convertible class A preferred stock, Series L, with a liquidation preference of $1,000 per share, payable on Dec. 15, 2025, to holders of record as of Nov. 28, 2025 [2] - A quarterly cash dividend of $351.56 per share was declared on its 5.625% noncumulative perpetual class A preferred stock, Series Y, with a liquidation preference of $25,000 per share, payable on Dec. 15, 2025, to holders of record as of Nov. 28, 2025 [3] - A quarterly cash dividend of $296.88 per share was declared on its 4.75% noncumulative perpetual class A preferred stock, Series Z, with a liquidation preference of $25,000 per share, payable on Dec. 15, 2025, to holders of record as of Nov. 28, 2025 [4] - A quarterly cash dividend of $293.75 per share was declared on its 4.70% noncumulative perpetual class A preferred stock, Series AA, with a liquidation preference of $25,000 per share, payable on Dec. 15, 2025, to holders of record as of Nov. 28, 2025 [5] - A quarterly cash dividend of $273.44 per share was declared on its 4.375% noncumulative perpetual class A preferred stock, Series CC, with a liquidation preference of $25,000 per share, payable on Dec. 15, 2025, to holders of record as of Nov. 28, 2025 [6] - A quarterly cash dividend of $265.63 per share was declared on its 4.25% noncumulative perpetual class A preferred stock, Series DD, with a liquidation preference of $25,000 per share, payable on Dec. 15, 2025, to holders of record as of Nov. 28, 2025 [7] Company Overview - Wells Fargo & Company is a leading financial services company with approximately $2.1 trillion in assets, providing a diversified set of banking, investment, and mortgage products and services [8]

As filed with the Securities and Exchange Commission on September 8, 2025. Registration No. 333-290119 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 (Amendment No. 2) To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AMERICAN REBEL HOLDINGS, INC. (Exact name of registrant as specified in its charter) | Nevada | 7372 | 47-3892903 | | --- | --- | --- | | (State or Other Jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | Incorporation or Organization ...

Financial Data and Key Metrics Changes - For Q3 2025, the company reported a net income of $1.12 per diluted share, an increase from $0.74 per diluted share in Q3 2024, attributed to unrealized gains on preferred stock and stock warrant investments [4] - Earnings available for distribution decreased to $0.51 per diluted share in Q3 2025 from $0.75 per diluted share in Q3 2024 [4] - Cash available for distribution also declined to $0.53 per diluted share in Q3 2025 from $0.67 per diluted share in Q3 2024 [5] - The company declared a regular dividend of $0.50 per share for Q3 2025, which was 1.06 times covered by cash available for distribution [5] - Book value per share increased by 8% from Q2 2025 to $18.79 per diluted share, primarily due to unrealized gains on preferred stock investments and stock warrants [5] Business Line Data and Key Metrics Changes - The portfolio consists of 88 investments with a total outstanding balance of $1.1 billion, allocated as follows: 47.3% multifamily, 33.9% life sciences, 15.9% single-family rental, 1.8% storage, and 1.1% marina [6] - The fixed income portfolio is allocated as follows: 27% CMBS B pieces, 26.5% mezzanine loans, 18.6% preferred equity investments, 12.4% revolving credit facilities, 10% senior loans, 4.2% IO strips, and 1.3% promissory notes [6] Market Data and Key Metrics Changes - The assets collateralizing investments are geographically allocated with 28.1% in Massachusetts, 15.5% in Texas, 8% in Georgia, and smaller percentages in California, Maryland, and Florida, reflecting a preference for Sunbelt markets [7] - The collateral on the portfolio is 87.4% stabilized, with a loan-to-value ratio of 54.9% and a weighted average debt service coverage ratio (DSCR) of 1.41 times [8] Company Strategy and Development Direction - The company is launching a Series C Preferred offering of $200 million at an 8% coupon, continuing to deploy capital at spreads of 400 basis points plus the cost of this capital [9] - The company is focused on maintaining a low leverage profile, which allows for various capital options to pursue growth opportunities [18] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the rental market outlook, anticipating positive revenue growth in 2026 for the first time in several years [12] - The life sciences sector is showing signs of stabilization with a significant lease signed with Lila Sciences, which is expected to drive leasing momentum [17][22] - The multifamily sector is expected to see new lease growth inflecting in major markets, with optimism for transaction volumes to increase dramatically in 2026 [36] Other Important Information - The company funded $42.5 million on a life sciences preferred and $6.5 million on a loan with a monthly coupon of SOFR +900 basis points during the quarter [5] - The company sold a multifamily property for $60 million, resulting in a $3.7 million gain [6] Q&A Session Summary Question: Updated view on the life sciences sector - Management noted that distress in the life sciences sector primarily affects projects capitalized shortly after COVID, while their investments are focused on first-to-fill assets in strong markets [21][22] Question: Thoughts on multifamily supply and bridge lending - Management acknowledged softness in the bridge lending space due to floating-rate loans originated in 2021-2022 but expressed optimism for new lease growth in constrained supply markets [35][36]

The share price of AT&T (NYSE: T ) has been under pressure lately as the telecom sector in the United States is changing. In this excellent preview by fellow author Vladimir Dimitrov, the key elements to look out for in next week’sHe is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital ga ...